The proportion of PD-L1+ tumors was highest in epithelioid sarcoma (100%), followed by synovial sarcoma (53%), rhabdomyosarcoma (38%) and Ewing sarcoma (33%), whereas mesenchymal chondrosarcoma tested negative for PD-L1 [114]. Here, CD274 is linked to synovial sarcoma.